Global meningococcal vaccine market is witnessing steady expansion as governments and healthcare organizations intensify efforts to prevent life-threatening meningococcal infections. Valued at USD 251 million in 2024, the market is projected to grow to USD 345 million by 2031, registering a CAGR of 4.8% during the forecast period.
Meningococcal vaccines are essential biological products that...
About
Koşullar
Gizlilik
Contact
Invest
Thai
English
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian